STELLA PHARMA
NEWS
December 25th, 2024
Stella Pharma Concludes MOU on Boron Neutron Capture Therapy System with Fujita Health University, Atransen Pharma, SHI, and Fujita
Stella Pharma Corporation has concluded a Memorandum of Understanding (MOU) to ……
December 10th, 2024
Observation Period Completed for Primary Endpoint – Phase II Clinical Trial in Patients with Angiosarcoma
We are pleased to announce the completion of the 90-day observation period for ……
December 6th, 2024
Paper published: Poly(vinyl alcohol) Potentiating an Inert D-Amino Acid-Based Drug for Boron Neutron Capture Therapy
The paper titled “Poly(vinyl alcohol) potentiating an inert D-amino acid-based ……
November 20th, 2024
Paper published: Research on Combination of Proton Beam Therapy and Boron Nuclear Capture Reaction
The Paper titled “Increased cell killing effect in neutron capture enhanced pro……